Pharmafile Logo
Pharmafocus logo
Advanced Search

UK’s branded pharma sales predicted to decline

May 1, 2009
Sales and Marketing NHS

As part of the UK government's drive to save £2.3 billion in the NHS during 2010-11, £550m will be cut …

News

Avastin fails in colon cancer study

April 30, 2009
Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …

News

Sanofi makes cuts to phase III pipeline

April 30, 2009
Research and Development Sanofi-Aventis

Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …

News

NICE could ease QALY to boost innovation

April 30, 2009
Research and Development NICE

NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …

News

Minister thanks pharma for help in swine flu fight

April 30, 2009
Research and Development h1n1

Health secretary Alan Johnson kept an appointment to address the ABPI's annual conference yesterday despite the spread of swine flu …

News

Developing health, developing profits

April 30, 2009
Research and Development, Sales and Marketing Pfizer, healthcare, working poor

Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …

Feature

Nexavar fails in melanoma study

April 30, 2009
Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …

News

Recession hits Merck KGaA profits

April 29, 2009
Sales and Marketing Merck Serono

Merck KGaA saw its profits fell through the floor for the first quarter this year due to a combination of …

News

Microdosing shows its mettle in cancer study

April 29, 2009
Research and Development Microdosing

Newly-released data has added additional weight to the evidence for microdosing studies as a means to predict whether or not …

News

UK scientists to examine swine flu

April 29, 2009
Research and Development h1n1

UK scientists will examine new samples of swine influenza as part of the global race to develop a vaccine against …

News

GSK pledges help in flu outbreak

April 28, 2009
Research and Development GSK, h1n1

GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …

News

IDIS and Ogilvy to promote named patient programme

April 28, 2009
Medical Communications, Sales and Marketing IDIS, Ogilvy

Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …

News

The changing face of Continuing Medical Education in Europe

April 28, 2009
Medical Communications, Sales and Marketing Continuing medical education, Europe

There is currently no unified approach to delivering Continuing Medical Education (CME) in Europe, and the provision of CME is …

Feature

Patheon takeover stymied by regulators

April 28, 2009
Manufacturing and Production Patheon

A hostile takeover bid for Canadian contract manufacturer Patheon by private equity firm JLL Partners has been blocked by the …

News

Pfizer taps UCL for stem cell expertise

April 28, 2009
Research and Development Pfizer, UCL, ophthalmology, regenerative medicine

 Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …

News

AZ’s Iressa to make comeback

April 28, 2009
Research and Development, Sales and Marketing AZ, Iressa

AstraZeneca's Iressa is set to make a comeback after a European committee recommended its use for a sub-group of lung …

News

Questions and answers

April 27, 2009
Medical Communications Pfizer, Q&A, communications

As a young child, I am reliably informed that "why" was my favourite word for an extended period. While that …

Feature

Mixed news for Biogen Idec on Tysabri

April 27, 2009
Manufacturing and Production Biogen

Biogen Idec has won approval for a new high-titre manufacturing process for its multiple sclerosis product Tysabri (natalizumab) which should …

News

GSK and Pfizer joint venture more than a defensive move

April 27, 2009
Research and Development, Sales and Marketing GSK, Pfizer

GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …

News

TBWAPaling Walters broadens European horizons

April 27, 2009
Medical Communications TBWA

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025